Clinical Trial Update: Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating gemcitabine plus nab-paclitaxel versus the FOLFIRINOX regimen with molecular profiling in patients with advanced pancreatic cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Pancreatic Cancer Research Team | Conditions: Stage IV Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED